Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 4 5 6 7 Last 

Arizona

Research Site
Phoenix Arizona

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Tucson Arizona

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

UPDATED

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Scottsdale Arizona

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tucson Arizona 85719

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Research Site
Los Angeles California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Los Angeles California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Stanford California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Fullerton California 92835

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Los Angeles California 90404

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco California 94155

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Francisco California 94115

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Luis Obispo California 93422

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Luis Obispo California 93401

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria California 93454

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Maria California 93454

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Santa Monica California 90404

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Stanford California 94305

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Colorado

Lakewood Colorado 80228

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lakewood Colorado 80228

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida

Research Site
Sarasota Florida

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Tampa Florida

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Orlando Florida 32804

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota Florida 34232

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Sarasota Florida 34239

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Georgia

Research Site
Atlanta Georgia

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Illinois

Research Site
Chicago Illinois

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indiana

Research Site
Indianapolis Indiana

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Indianapolis Indiana

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

Lafayette Indiana

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Lafayette Indiana 47905

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Maryland

UPDATED

Baltimore Maryland 21237

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Research Site
Boston Massachusetts

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

Boston Massachusetts 02215

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Michigan

Detroit Michigan 48201

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Minnesota

Research Site
Minneapolis Minnesota

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More ▼

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Alvimopan and Placebo to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

First 1 2 3 4 5 6 7 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.